Current Management of Stage IIIA (N2) Non-Small-Cell Lung Cancer Role of Perioperative Immunotherapy, and Tyrosine Kinase Inhibitors

被引：1
作者：
Bryan, Darren S. [1 ]
Donington, Jessica S. [1 ]
机构：
[1] Univ Chicago Med, Dept Surg, Sect Thorac Surg, Room S-546 MC 5047,5841 South Maryland Ave, Chicago, IL 60637 USA
来源：
THORACIC SURGERY CLINICS | 2023年 / 33卷 / 02期
关键词：
Non-small-cell lung cancer; Multimodality therapy; Surgery; Stage III; Induction therapy; Immunotherapy; NEOADJUVANT THERAPY; SURGICAL RESECTION; PLUS CHEMOTHERAPY; ADJUVANT THERAPY; NIVOLUMAB; PHASE-3; PEMBROLIZUMAB; RADIOTHERAPY; OSIMERTINIB; MUTATIONS;
D O I：
10.1016/j.thorsurg.2023.01.006
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
There have been numerous recent advances in the treatmetn of stage IIIA non-small cell lung cancer. The most significant involve the addition of targeted therapies adn immune checkpoint inhibitors into perioperative care. These exciting advances are improving survival in this challenging patient population, but some-decade old controveries around the definition of resectability, prognositic importance of tumor response to induction therapy, and the role of pneumonectomy persist. Copyright © 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码：189 / 196
页数：8
相关论文
共 40 条
  • [1] AJCC, 2016, AJCC Cancer Staging Manual
  • [2] Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial
    Albain, Kathy S.
    Swann, R. Suzanne
    Rusch, Valerie W.
    Turrisi, Andrew T., III
    Shepherd, Frances A.
    Smith, Colum
    Chen, Yuhchyau
    Livingston, Robert B.
    Feins, Richard H.
    Gandara, David R.
    Fry, Willard A.
    Darling, Gail
    Johnson, David H.
    Green, Mark R.
    Miller, Robert C.
    Ley, Joanne
    Sause, Willliam T.
    Cox, James D.
    [J]. LANCET, 2009, 374 (9687) : 379 - 386
  • [3] Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial
    Altorki, Nasser K.
    McGraw, Timothy E.
    Borczuk, Alain C.
    Saxena, Ashish
    Port, Jeffrey L.
    Stiles, Brendon M.
    Lee, Benjamin E.
    Sanfilippo, Nicholas J.
    Scheff, Ronald J.
    Pua, Bradley B.
    Gruden, James F.
    Christos, Paul J.
    Spinelli, Cathy
    Gakuria, Joyce
    Uppal, Manik
    Binder, Bhavneet
    Elemento, Olivier
    Ballman, Karla, V
    Formenti, Silvia C.
    [J]. LANCET ONCOLOGY, 2021, 22 (06) : 824 - 835
  • [4] Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
    Antonia, S. J.
    Villegas, A.
    Daniel, D.
    Vicente, D.
    Murakami, S.
    Hui, R.
    Kurata, T.
    Chiappori, A.
    Lee, K. H.
    de Wit, M.
    Cho, B. C.
    Bourhaba, M.
    Quantin, X.
    Tokito, T.
    Mekhail, T.
    Planchard, D.
    Kim, Y. -C.
    Karapetis, C. S.
    Hiret, S.
    Ostoros, G.
    Kubota, K.
    Gray, J. E.
    Paz-Ares, L.
    Carpeno, J. de Castro
    Faivre-Finn, C.
    Reck, M.
    Vansteenkiste, J.
    Spigel, D. R.
    Wadsworth, C.
    Melillo, G.
    Taboada, M.
    Dennis, P. A.
    Ozguroglu, M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (24) : 2342 - 2350
  • [5] Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
    Antonia, S. J.
    Villegas, A.
    Daniel, D.
    Vicente, D.
    Murakami, S.
    Hui, R.
    Yokoi, T.
    Chiappori, A.
    Lee, K. H.
    de Wit, M.
    Cho, B. C.
    Bourhaba, M.
    Quantin, X.
    Tokito, T.
    Mekhail, T.
    Planchard, D.
    Kim, Y. -C.
    Karapetis, C. S.
    Hiret, S.
    Ostoros, G.
    Kubota, K.
    Gray, J. E.
    Paz-Ares, L.
    de Castro Carpeno, J.
    Wadsworth, C.
    Melillo, G.
    Jiang, H.
    Huang, Y.
    Dennis, P. A.
    Ozguroglu, M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (20) : 1919 - 1929
  • [6] Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma
    Blank, Christian U.
    Rozeman, Elisa A.
    Fanchi, Lorenzo F.
    Sikorska, Karolina
    van de Wiel, Bart
    Kvistborg, Pia
    Krijgsman, Oscar
    van den Braber, Marlous
    Philips, Daisy
    Broeks, Annegien
    van Thienen, Johannes, V
    Mallo, Henk A.
    Adriaansz, Sandra
    ter Meulens, Sylvia
    Pronk, Loes M.
    Grijpink-Ongering, Lindsay G.
    Bruining, Annemarie
    Gittelman, Rachel M.
    Warren, Sarah
    van Tinteren, Harm
    Peeper, Daniel S.
    Haanen, John B. A. G.
    van Akkooi, Alexander C. J.
    Schumacher, Ton N.
    [J]. NATURE MEDICINE, 2018, 24 (11) : 1655 - +
  • [7] Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
    Borghaei, H.
    Paz-Ares, L.
    Horn, L.
    Spigel, D. R.
    Steins, M.
    Ready, N. E.
    Chow, L. Q.
    Vokes, E. E.
    Felip, E.
    Holgado, E.
    Barlesi, F.
    Kohlhaeufl, M.
    Arrieta, O.
    Burgio, M. A.
    Fayette, J.
    Lena, H.
    Poddubskaya, E.
    Gerber, D. E.
    Gettinger, S. N.
    Rudin, C. M.
    Rizvi, N.
    Crino, L.
    Blumenschein, G. R.
    Antonia, S. J.
    Dorange, C.
    Harbison, C. T.
    Finckenstein, F. Graf
    Brahmer, J. R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (17) : 1627 - 1639
  • [8] Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
    Brahmer, Julie
    Reckamp, Karen L.
    Baas, Paul
    Crino, Lucio
    Eberhardt, Wilfried E. E.
    Poddubskaya, Elena
    Antonia, Scott
    Pluzanski, Adam
    Vokes, Everett E.
    Holgado, Esther
    Waterhouse, David
    Ready, Neal
    Gainor, Justin
    Aren Frontera, Osvaldo
    Havel, Libor
    Steins, Martin
    Garassino, Marina C.
    Aerts, Joachim G.
    Domine, Manuel
    Paz-Ares, Luis
    Reck, Martin
    Baudelet, Christine
    Harbison, Christopher T.
    Lestini, Brian
    Spigel, David R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (02) : 123 - 135
  • [9] The Role of Surgery in Management of Locally Advanced Non-Small Cell Lung Cancer
    Bryan, Darren S.
    Donington, Jessica S.
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (04)
  • [10] Comparing the benefits of chemoradiotherapy and chemotherapy for resectable stage III A/N2 non-small cell lung cancer: a meta-analysis
    Chen, Yuqiao
    Peng, Xiong
    Zhou, Yuan
    Xia, Kun
    Zhuang, Wei
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2018, 16
1234